Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.247,09
0,47%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GlycoMimetics Inc (GLYC) GlycoMimetics Inc (GLYC) Notizie

GlycoMimetics Inc

GLYC
0,3125
-0,0075 (-2,34%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202414:00PRNUSCrescent Biopharma to Present at Jefferies London Healthcare..
07/11/202422:47EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/11/202422:42EDGAR2Form 8-K - Current report
06/11/202423:41EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
06/11/202413:00BWGlycoMimetics Announces New Uproleselan Clinical Data Will..
04/11/202422:26EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
04/11/202420:01EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
29/10/202415:00APSBiotech Up Over +100% Premarket Following Merger And Funding..
29/10/202413:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/10/202413:09EDGAR2Form 8-K - Current report
29/10/202412:00BWGlycoMimetics Enters Into Acquisition Agreement With..
29/10/202411:30BWGlycoMimetics Announces National Cancer Institute Phase 2/3..
15/8/202423:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/8/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/7/202421:55EDGAR2Form 8-K - Current report
30/7/202401:24EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
25/7/202415:00BWGlycoMimetics Announces Strategic Review and Corporate..
13/6/202422:30EDGAR2Form 8-K - Current report
04/6/202415:30EDGAR2Form 8-K - Current report
04/6/202413:00BWGlycoMimetics Announces Comprehensive Results from Pivotal..
29/5/202422:01BWGlycoMimetics to Host Key Opinion Leader Event to Review..
09/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:01EDGAR2Form 8-K - Current report
06/5/202412:00BWGlycoMimetics Announces Results of Pivotal Phase 3 Study of..
25/4/202413:00BWGlycoMimetics to Report First Quarter 2024 Financial Results..
27/3/202412:00BWGlycoMimetics Reports Highlights and Financial Results for..
13/3/202412:00BWGlycoMimetics to Report Fourth Quarter and 2023 Full Year..
01/3/202415:16EDGAR2Form 8-K - Current report
26/2/202413:00BWGlycoMimetics to Participate in Upcoming Cowen 44th Annual..
12/2/202413:00BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:00BWGlycoMimetics Announces Positive Initial Safety and..
03/1/202413:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
02/1/202422:30EDGAR2Form 8-K - Current report
02/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202318:00BWGlycoMimetics Announces Independent Presentations on..
Apertura: 0,35 Min: 0,3113 Max: 0,35
Chiusura: 0,32

La tua Cronologia

NASDAQ
GLYC
GlycoMimetics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network